Market Tracker

05/28 4:45pm ET

Synageva BioPharma Corp (NASDAQ:GEVA)

214.59
Delayed Data
As of May 28
 -1.18 / -0.55%
Today’s Change
60.19
Today|||52-Week Range
218.80
+131.26%
Year-to-Date

Today’s Trading

Previous close215.77
Today’s open215.19
Day’s range213.45 - 215.80
Volume302,139
Average volume (3 months)786,209
Market cap$8.0B
Dividend yield--
Data as of 4:00pm ET, 05/28/2015

Growth & Valuation

Earnings growth (last year)-73.24%
Earnings growth (this year)-25.49%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-51.46%
P/E ratioNM
Price/Sales467.65
Price/Book15.21

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc+2.83+1.49%
XONIntrexon Corp-0.27-0.66%
JUNOJuno Therapeutics In...+3.76+8.03%
CTLTCatalent Inc+0.60+1.92%
Data as of 4:02pm ET, 05/28/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)-$1.79
Annual revenue (last year)$6.5M
Annual profit (last year)-$192.6M
Net profit margin-2,967.47%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Operating Officer
Robert B. Bazemore
Corporate headquarters
Lexington, Massachusetts

Forecasts